Form 8-K - Current report:
SEC Accession No. 0001193125-19-239961
Filing Date
2019-09-06
Accepted
2019-09-06 16:05:57
Documents
1
Period of Report
2019-09-05
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K d692586d8k.htm 8-K 17821
  Complete submission text file 0001193125-19-239961.txt   18975
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 225 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 225 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

EIN.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35670 | Film No.: 191079715
SIC: 2834 Pharmaceutical Preparations